While human studies on the effects of DSIP are not definitive, the neuropeptides promotion of slow-wave sleep is reported across several preclinical studies [4]
After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology Jean-Michel Dogns Post The benefits of GLP-1 drugs beyond obesity Excellent review on the Glucagon-like peptide1based medicines #diabetes and weight lossindependent actions
Glutathione therapy, whether administered orally, topically, or intravenously, provides a variety of choices for people looking to improve the radiance and vitality of their skin
It performs steadily in inhibiting melanin synthesis and is ideal for high-end users with established whitening habits
Notably, some studies have shown that vitamin K1 (chlorophylquinone) can compensate for the damage to the anti-ferroptosis defense mechanism when GPX4 was inhibited or when used with the DHODH inhibitor BQR, and its anti-ferroptosis efficacy was found to be equivalent to that of ferrostatin-1 (Fer-1) [61]